These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33239656)

  • 1. Multiple myeloma hinders erythropoiesis and causes anaemia owing to high levels of CCL3 in the bone marrow microenvironment.
    Liu L; Yu Z; Cheng H; Mao X; Sui W; Deng S; Wei X; Lv J; Du C; Xu J; Huang W; Xia S; An G; Zhou W; Ma X; Cheng T; Qiu L; Hao M
    Sci Rep; 2020 Nov; 10(1):20508. PubMed ID: 33239656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukemia cell infiltration causes defective erythropoiesis partially through MIP-1α/CCL3.
    Wang Y; Gao A; Zhao H; Lu P; Cheng H; Dong F; Gong Y; Ma S; Zheng Y; Zhang H; Zhang Y; Xu J; Zhu X; Yuan W; Zhang X; Hao S; Cheng T
    Leukemia; 2016 Sep; 30(9):1897-908. PubMed ID: 27109512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
    Bouchnita A; Eymard N; Moyo TK; Koury MJ; Volpert V
    Am J Hematol; 2016 Jun; 91(4):371-8. PubMed ID: 26749142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
    Bruns I; Cadeddu RP; Brueckmann I; Fröbel J; Geyh S; Büst S; Fischer JC; Roels F; Wilk CM; Schildberg FA; Hünerlitürkoglu AN; Zilkens C; Jäger M; Steidl U; Zohren F; Fenk R; Kobbe G; Brors B; Czibere A; Schroeder T; Trumpp A; Haas R
    Blood; 2012 Sep; 120(13):2620-30. PubMed ID: 22517906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel role for CCL3 (MIP-1α) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function.
    Vallet S; Pozzi S; Patel K; Vaghela N; Fulciniti MT; Veiby P; Hideshima T; Santo L; Cirstea D; Scadden DT; Anderson KC; Raje N
    Leukemia; 2011 Jul; 25(7):1174-81. PubMed ID: 21403648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derepression of the DNA Methylation Machinery of the
    Yu L; Takai J; Otsuki A; Katsuoka F; Suzuki M; Katayama S; Nezu M; Engel JD; Moriguchi T; Yamamoto M
    Mol Cell Biol; 2017 Apr; 37(8):. PubMed ID: 28069743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.
    Li Y; Zheng Y; Li T; Wang Q; Qian J; Lu Y; Zhang M; Bi E; Yang M; Reu F; Yi Q; Cai Z
    Oncotarget; 2015 Sep; 6(27):24218-29. PubMed ID: 26155942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/CXCR4 and CCR1.
    Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW
    Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease.
    Dairaghi DJ; Oyajobi BO; Gupta A; McCluskey B; Miao S; Powers JP; Seitz LC; Wang Y; Zeng Y; Zhang P; Schall TJ; Jaen JC
    Blood; 2012 Aug; 120(7):1449-57. PubMed ID: 22618707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of CCL3 on osteoblast in myeloma bone disease].
    Zhao S; Fu R; Liu H; Wang Y; Li L; Liu C; Zhang T; Ding S; Gao S; Ruan E; Qu W; Wang H; Wang X; Wu Y; Song J; Liu H; Guan J; Shao Z
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):623-7. PubMed ID: 25052606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.
    Silvestris F; Cafforio P; Tucci M; Dammacco F
    Blood; 2002 Feb; 99(4):1305-13. PubMed ID: 11830480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCR1 as a target for multiple myeloma.
    Vallet S; Anderson KC
    Expert Opin Ther Targets; 2011 Sep; 15(9):1037-47. PubMed ID: 21609295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of GATA1 levels in erythropoiesis.
    Gutiérrez L; Caballero N; Fernández-Calleja L; Karkoulia E; Strouboulis J
    IUBMB Life; 2020 Jan; 72(1):89-105. PubMed ID: 31769197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial Cell-Selective Adhesion Molecule Expression in Hematopoietic Stem/Progenitor Cells Is Essential for Erythropoiesis Recovery after Bone Marrow Injury.
    Sudo T; Yokota T; Okuzaki D; Ueda T; Ichii M; Ishibashi T; Isono T; Habuchi Y; Oritani K; Kanakura Y
    PLoS One; 2016; 11(4):e0154189. PubMed ID: 27111450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MM-associated anemia: more than "crowding out" HSPCs.
    Podar K
    Blood; 2012 Sep; 120(13):2539-40. PubMed ID: 23019201
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
    Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
    Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of immature erythroid progenitor cell proliferation by macrophage inflammatory protein-1alpha by interacting mainly with a C-C chemokine receptor, CCR1.
    Su S; Mukaida N; Wang J; Zhang Y; Takami A; Nakao S; Matsushima K
    Blood; 1997 Jul; 90(2):605-11. PubMed ID: 9226160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of causes for anemia in patients with multiple myeloma].
    Rokicka-Piotrowicz M; Paszkowska M; Król M; Król M; Kuratowska Z
    Pol Arch Med Wewn; 2000 Dec; 104(6):843-51. PubMed ID: 11424663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow expression of CCL3 is not correlated with the extent of lytic bone lesions.
    Cohen Y; Gutwein O; Garach-Jehoshua O; Bar-Haim A; Kornberg A
    Acta Haematol; 2014; 132(2):129-33. PubMed ID: 24556596
    [No Abstract]   [Full Text] [Related]  

  • 20. [Involvement of apoptosis and proinflammatory cytokines in the pathogenesis of anemia in multiple myeloma].
    Grzaśko N
    Postepy Hig Med Dosw (Online); 2004; 58():364-71. PubMed ID: 15536394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.